Skip to main content
Equibles
BLCO logo

BLCO · Bausch & Lomb Corp · Metrics

Track BLCO — free

Use BLCO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BLCO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$20.00 -0.40 (-1.96%) At close · Oct 30 Q3 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$7.15B
Shares
357.50M
Volume · Oct 30 1.43M Avg daily vol (3M) 553.46K

BLCO metrics

95 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$20.00
Market cap
$7.15B

Price action

20 metrics
Price change (1W)
+14.5%
Price change (30D)
+18.1%
Price change (3M)
+18.3%
Price change (6M)
+22.6%
Price change (YTD)
+17.1%
Price change (1Y)
+32.1%
Trailing year
Price change (5Y)
—
52-week high
$20.40
52-week low
$14.56
Change from 52-week high
-2.0%
Change from 52-week low
+37.4%
Annualized volatility
33.0%
Annualized volatility (3M)
39.9%
Beta
1.0
RSI (14D)
73.8
Price vs SMA 50
+15.3%
Price vs SMA 200
+20.0%
Avg volume (3M)
553,463
Relative volume
2.6
Average dollar volume
$9.87M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
357.50M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.2×
reciprocal yield 46.5%
EV / EBITDA
14.8×
reciprocal yield 6.8%
EV / EBIT
30.4×
reciprocal yield 3.3%
P / sales
1.3×
reciprocal yield 75.8%
P / book
1.1
reciprocal yield 90.1%
FCF yield
3.5%
TTM · current market cap
Buyback yield
—
P / FCF
28.4
reciprocal yield 3.5%
P / operating cash flow
12.9
reciprocal yield 7.7%
Earnings yield
-1.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.2×
reciprocal yield 46.5%
EV / revenue historical average (5Y)
2.2×
reciprocal yield 46.2%
EV / EBIT historical average (3Y)
89.5×
reciprocal yield 1.1%
EV / EBIT historical average (5Y)
82.7×
reciprocal yield 1.2%
EV / EBITDA historical average (3Y)
17.9×
reciprocal yield 5.6%
EV / EBITDA historical average (5Y)
17.7×
reciprocal yield 5.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-28

Profitability

9 metrics
Gross margin
—
Operating margin
7.1%
Trailing 12 months
Net margin
-2.0%
Gross profit (TTM)
—
Operating profit (TTM)
$383.00M
Net income (TTM)
−$111.00M
Trailing 12 months
Diluted EPS (TTM)
$-0.31
FCF margin
4.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$15.17
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$1.07
EBITDA per diluted share (TTM)
$2.20
Net income per diluted share (TTM)
$-0.31
Operating cash flow per diluted share (TTM)
$1.55
Free cash flow per diluted share (TTM)
$0.70
Capital expenditures per diluted share (TTM)
$0.85
R&D per diluted share (TTM)
$1.12
Stock compensation per diluted share (TTM)
$0.49
Book value per share
$18.20

Growth

11 metrics
Revenue growth YoY
+7.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$5.42B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.1%
Year over year · more shares
Revenue CAGR (3Y)
+10.6%
Revenue CAGR (5Y)
+8.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-1.7%
Return on assets
-0.8%
Debt / equity
0.8
Current ratio
1.6
EBITDA (TTM)
$787.00M
Free cash flow (TTM)
$252.00M
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
5.7
Return on invested capital
—
Trailing 12 months
Net cash
−$4.50B
Latest balance sheet
Cash & equivalents
$513.00M
Total assets
$13.96B
Total debt
$5.02B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$554.00M
Capital expenditures (TTM)
$302.00M
R&D (TTM)
$400.00M
SG&A (TTM)
$2.25B
Stock compensation (TTM)
$173.00M
R&D / revenue
7.4%
Stock compensation / revenue
3.2%

Ownership (13F)

9 metrics
13F filers
98
13F filer change QoQ
+2
Institutional ownership
10.8%
Conviction holders (share of 13F filers)
4.1%
Crowding (high-turnover and private-fund holders)
6.5%
Private-fund adviser ownership
5.2%
Active holders' share change QoQ
+0.8%
Holder tenure
9.2
Price vs estimated holder cost
+6.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.7%
Latest settlement · 3.6 days to cover
Days to cover
3.6d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.19M
Insider-sentiment score
29 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1860742 CUSIP 071705107 13F (30d) 13 filings 13 filers Visit website Investor relations